Targeting intracellular checkpoints to enhance NK cell immunotherapy

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient outcomes in various cancers.